![Keith Katkin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Katkin
Président chez
ELEDON PHARMACEUTICALS, INC.
Fortune : 2 M $ au 31/08/2026
Profil
Mr. Keith A. Katkin is an Independent Director at Emergent BioSolutions, Inc., a Chairman at Eledon Pharmaceuticals, Inc. and an Independent Director at Syndax Pharmaceuticals, Inc. He is on the Board of Directors at Emergent BioSolutions, Inc., Syndax Pharmaceuticals, Inc., Brain Injury Association of America, Inc. and Transposon Therapeutics, Inc. Mr. Katkin was previously employed as a Chief Executive Officer & Director by Urovant Sciences Ltd., a President, Chief Executive Officer & Director by Urovant Sciences, Inc., a Chairman by Otic Pharma Ltd., an Independent Director by Rigel Pharmaceuticals, Inc., an Independent Class III Director by Carbylan Therapeutics, Inc., a President, Chief Executive Officer & Director by Avanir Pharmaceuticals, Inc., and a Vice President-Commercial Development by Peninsula Pharmaceuticals, Inc. He also served on the board at CoverMyMeds LLC and MC10, Inc. He received his undergraduate degree from Indiana University and an MBA from UCLA Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/03/2026 | 90 000 ( 0,1 % ) | 2 M $ | 31/08/2026 | |
| 30/04/2026 | 96 294 ( 0,19 % ) | 587 393 $ | 31/08/2026 | |
| 31/03/2026 | 677 ( 0 % ) | 2 017 $ | 31/08/2026 |
Postes actifs de Keith Katkin
| Sociétés | Poste | Début |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 29/03/2017 |
| ELEDON PHARMACEUTICALS, INC. | Président | 01/05/2017 |
| EMERGENT BIOSOLUTIONS INC. | Directeur/Membre du Conseil | 01/04/2022 |
Brain Injury Association of America, Inc.
 Brain Injury Association of America, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for rehabilitation, lifelong disease management and individualized services | Directeur/Membre du Conseil | - |
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. BiotechnologyHealth Technology Develops orally administered therapies to treat neurodegenerative, autoimmune and aging-related diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Keith Katkin
| Sociétés | Poste | Fin |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/05/2022 |
| UROVANT SCIENCES LTD. | Directeur Général | 23/03/2020 |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies for urologic conditions | Directeur Général | 01/01/2020 |
CoverMyMeds LLC
 CoverMyMeds LLC Information Technology ServicesTechnology Services Provides healthcare data-driven technology services | Directeur/Membre du Conseil | 01/04/2017 |
| ░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Keith Katkin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Commercial Services |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
MC10, Inc.
 MC10, Inc. Medical SpecialtiesHealth Technology Manufactures clinical metrics wearable medical devices | Health Technology |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Health Technology |
Brain Injury Association of America, Inc.
Brain Injury Association of America, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for rehabilitation, lifelong disease management and individualized services | Commercial Services |
CoverMyMeds LLC
CoverMyMeds LLC Information Technology ServicesTechnology Services Provides healthcare data-driven technology services | Technology Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies for urologic conditions | Health Technology |
Urovant Sciences Ltd.
 Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for urologic conditions | Health Technology |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. BiotechnologyHealth Technology Develops orally administered therapies to treat neurodegenerative, autoimmune and aging-related diseases | Health Technology |
